The weekly litigation news digest is live. Subscribe now

IP Verse

Purification Of Recombinantly Produced Polypeptides - EP2997036

The patent EP2997036 was granted to Medimmune on Mar 3, 2021. The application was filed on May 13, 2014 under application number EP14797310A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2997036

MEDIMMUNE
Application Number
EP14797310A
Filing Date
May 13, 2014
Status
Granted And Under Opposition
Jan 29, 2021
Publication Date
Mar 3, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GLAXOSMITHKLINEDec 3, 2021BELLADMISSIBLE
OETKEDec 3, 2021WALLINGER RICKER SCHLOTTER TOSTMANNADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP2578286
INTERNATIONAL-SEARCH-REPORTUS2012101262
INTERNATIONAL-SEARCH-REPORTUS7807799
INTERNATIONAL-SEARCH-REPORTWO2010141039
INTERNATIONAL-SEARCH-REPORTWO2014066468
INTERNATIONAL-SEARCH-REPORTWO2014133460
OPPOSITIONWO2011073389
OPPOSITIONWO2014141150
OPPOSITIONWO2014186350
OTHERWO2014141150
SEARCHWO2015166072

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents